Gene transfer for ischemic cardiovascular disease: is this the end of the beginning or the beginning of the end?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,General Medicine
Link
http://www.nature.com/articles/ncpcardio0136.pdf
Reference50 articles.
1. Scandinavian Simvastatin Survival Study Group (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344: 1383–1389
2. Serruys PW et al. (1994) A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 331: 489–495
3. Fischman DL et al. (1994) A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 331: 496–501
4. Isner JM et al. (2001) Assessment of risks associated with cardiovascular gene therapy in human subjects. Circ Res 89: 389–400
5. Nabel EG et al. (1989) Recombinant gene expression in vivo within endothelial cells of the arterial wall. Science 244: 1342–1344
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effect of intramyocardial allogenic biomaterial injection on angiogenesis and postischemic scar remodeling in rats;Russian Journal of Transplantology and Artificial Organs;2020-10-06
2. Growth Hormone (GH) and Cardiovascular System;International Journal of Molecular Sciences;2018-01-18
3. Disruption of Nrf2 Signaling Impairs Angiogenic Capacity of Endothelial Cells: Implications for Microvascular Aging;The Journals of Gerontology Series A: Biological Sciences and Medical Sciences;2012-01-04
4. Advances in Gene-Based Therapy for Heart Failure;Journal of Cardiovascular Translational Research;2008-05-29
5. Gene therapy and stem cell technology;Essential Interventional Cardiology;2008
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3